Health Canada Approves Pfizer Covid 19 Vaccine For Children Aged Six Months To Four Years

Health Canada today approved Pfizer’s COVID-19 vaccine for use in children between the ages of six months and four years.
The federal department says that after a thorough and independent scientific review of the evidence, it concluded that the benefits of Pfizer-BioNTech’s Comirnaty vaccine outweigh the potential risks to children.
It is the second vaccine approved for this age group, after Health Canada approved Moderna’s Spikevax vaccine in July.
Health Canada says it approves a three-dose primary vaccine series for children under five, with three weeks between the first and second doses and eight weeks between the second and third doses.
The department says the vaccines, which target the original strain of COVID-19, remain effective in preventing serious illness, hospitalization and death.
The government recently approved a newer version of Moderna’s vaccine that targets the Omicron variant of COVID-19, but its use has not yet been approved for the younger cohort.
This report by The Canadian Press was first published on September 9, 2022.